Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$404,888
-$2,272,539 QoQ
Shares Held
1,609
-89.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3,367
of 4,153 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GROUP ONE TRADING LLC holds $26,089,534 across 7 Drug Manufacturers - General names. ABBV ranks #5 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
868,402 | $20,911,120 | |
| 2 | NVO |
Novo Nordisk A S
|
63,042 | $3,022,233 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,890 | $996,822 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
7,041 | $405,702 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,609 | $404,888 | |
| 6 | SNY |
Sanofi
|
8,127 | $346,697 | |
| 7 | AMRN |
Amarin Corp Plc\Uk
|
130 | $2,072 |
All Filings in ABBV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $404,888 | 1,609 | Shares | Sole | 2026-08-14 | |
| 2024-06-30 | $2,677,427 | 15,610 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,016,401 | 33,039 | Shares | Sole | 2024-05-10 | |
| 2020-06-30 | $5,541,573 | 56,443 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,345,230 | 135,782 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||